VIAV — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-04-30

• In 2025, the U.S. administration imposed additional, broad-based tariffs, under the International Emergency Economic Powers Act (IEEPA), which were then struck down by the U.S. Supreme Court as unconstitutional. In 2026, the administration then imposed temporary replacement tariffs. These, and any o…

• •GAAP net income of $6.4 million, down $13.1 million or 67.2% year-over-year.

• Net IncomeDiluted EPSNet IncomeDiluted EPSNet (Loss) IncomeDiluted EPSNet IncomeDiluted EPS

• Items reconciling GAAP Net Income (Loss) and EPS to Non-GAAP Net Income and EPS:

• (1)Included in the three months ended March 28, 2026 are charges of $3.9 million related to the write off of property, plant and equipment, $0.3 million of accelerated depreciation and other charges unrelated to core operating performance. In addition, included in the nine months ended March 28, 202…

Text removed vs the prior filing · source: 10-Q · 2026-01-29

• The U.S. administration has implemented and could implement further broad-based, updated global tariffs and the situation continues to be dynamic and evolving. As we operate in this challenging environment, we are focused on continuing to deliver our products and services to our customers. Given our…

• •Non-GAAP operating margin of 19.3%, up 440 bps year-over-year.

• Other charges (benefits) unrelated to core operating performance(1)

• Net (Loss) IncomeDiluted EPSNet IncomeDiluted EPSNet (Loss) IncomeDiluted EPSNet IncomeDiluted EPS

• Items reconciling GAAP Net (Loss) Income and EPS to Non-GAAP Net Income and EPS:

Text added vs the prior filing · source: 10-Q · 2026-04-30

• Trade tensions between the U.S. and China have continued to escalate, with the U.S. and China both imposing a variety of trade barriers against the other, including various export control restrictions and tariffs.

• For example, in 2025, in connection with our acquisition of Spirent’s HSE and CE business, we entered into a $600 million 7-year term loan facility and successfully allocated the loan to prospective lenders at an initial interest rate of SOFR+2.50% and an original issue price of 99.75%. The term loa…

Text removed vs the prior filing · source: 10-Q · 2026-01-29

• The U.S. and China have been engaged in protracted negotiations over the Chinese government’s acts, policies, and practices related to technology transfer, intellectual property, and innovation.

• For example, in March 2025, we obtained commitments for a $425 million 7-year term loan facility in connection with our acquisition of Spirent’s HSE and CE business. We subsequently marketed and upsized to a $600 million 7-year term loan facility and successfully allocated the loan to prospective le…

Text added vs the prior filing · source: 10-Q · 2026-04-30

• None of VIAVI’s directors or Section 16 officers adopted, modified or terminated a trading arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or a “non-Rule” 10b5–1 trading arrangement, as those terms are defined in Regulation S-K, Item 408, during the fiscal quarte…

Text removed vs the prior filing · source: 10-Q · 2026-01-29

• On November 7, 2025, Luke Scrivanich, Senior Vice President, General Manager OSP of VIAVI, entered into a prearranged trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of an indeterminable number of shares of common stock. Mr. Scrivanich’s plan begins on…

• None of VIAVI’s other directors or Section 16 officers adopted, modified or terminated a trading arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or a “non-Rule” 10b5–1 trading arrangement, as those terms are defined in Regulation S-K, Item 408, during the fiscal …